sh-Polypeptide-59 for Hair Regrowth

Created on 11/09/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / GPT 6 – Audit

sh-Polypeptide-59 is a cosmetic protein ingredient used in scalp-care products for hair regrowth. Animal and cell experiments support interest, but dependable regrowth in people has not been demonstrated. Hair benefit remains speculative. Related prescription wound-gel evidence cannot determine repeated cosmetic scalp-use risks. Supplier concentrations do not establish a validated regimen; long-term safety and exposure remain uncertain. (Full Review)

Protocol

Dose:
1–10 parts per million
Supplier cosmetic formulation range, not a clinically validated hair-regrowth dose; no evidence-based application volume.
Route:
Topical cosmetic use
Wound-gel regimens and mouse injection schedules do not supply a human scalp protocol.
Timing:
No established best time of day
Morning versus evening, single versus split applications, and minimum contact time have not been compared.
Time to effect
Time to effect:
No reliable human time-to-regrowth estimate
For isolated sh-Polypeptide-59; mouse hair-cycle timing cannot supply one.

Benefits

Contraindications
  • Application-site cancer: Avoidance is inferred.
  • Known sensitivity to the formulation: Avoidance is inferred.
Key Interactions
Theoretical (inferred from mechanism)
  • Barrier-disrupting treatments: Microneedling, ablative lasers, or irritating topical products such as tretinoin.

Risk & Side Effects

  • High:
  • Medium:
  • Low: Local Rash and Irritation; Cancer Promotion
  • Speculative: Unwanted Local Tissue Growth

Monitoring

Marker Target Why
Hair density in a fixed scalp area No established target; track change from baseline Intended efficacy outcome
Scalp redness and persistent lesions No established target; track new changes from baseline Safety check that may change use

Cadence: Illustrative, not validated: baseline and monthly photographs; review at three and six months. Persistent irritation warrants earlier assessment. These intervals imply no expected response time.

Qualitative Assessment

  • Appearance: Consistent photographs and perceived coverage distinguish repeatable change from styling variation.
  • Tolerability: Itching, burning, tenderness, and visible irritation assess formulation acceptability.
  • Attribution: An application and co-treatment record documents adherence and competing explanations; uncontrolled personal observation cannot establish causality.